Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the hyperpolarization-activated cyclic nucleotide-gated channel blocker class. 1 active patents protecting 1 drugs. First major cliff: 2026. Daily refresh.

1
Drugs in class
1
Active US patents
69/100
Avg vulnerability
—
Annual revenue covered

Originators

Amgen 1 patents

Cliff calendar — next 15 years

1
26

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Corlanor
IVABRADINE
 Amgen 1 69 — 2026-12-12

Most attackable patents

Patent Drug Type Vuln Expiry
7867996 Corlanor method of use 80 2026-12-12

Strongest defences

Patent Drug Type Vuln Expiry
7867996 Corlanor method of use 80 2026-12-12

Related